Frederick Ferri, CEO of PAOG’s target medical cannabis acquisition said, "Doctors involved in research with our extracts have given me feedback that our extracts are superior to those of GW Pharmaceuticals.”. GW pharm (gwph) PPS is $129 $JADA$SBFM$CYDY$RNWF$AIMH$FBpic.twitter.com/8z7iJ7Ing0